Curcumin and nano-curcumin applications in psychiatric disorders

被引:0
|
作者
Mohammadzadeh, R. [1 ]
Fathi, M. [1 ]
Pourseif, M. M. [1 ]
Omidi, Y. [2 ]
Farhang, S. [3 ]
Jalali, M. Barzegar [1 ]
Valizadeh, H. [1 ]
Nakhlband, A. [3 ]
Adibkia, K. [1 ]
机构
[1] Tabriz Univ Med Sci, Res Ctr Pharmaceut Nanotechnol, Tabriz, Iran
[2] Nova Southeastern Univ, Coll Pharm, Dept Pharmaceut Sci, Ft Lauderdale, FL USA
[3] Tabriz Univ Med Sci, Razi Psychiat Hosp, Res Ctr Psychiat & Behav Sci, Elgoli St,Block 2, Tabriz 5971919143, Iran
关键词
curcumin; nanocurcumin; psychiatric disorders; NF-KAPPA-B; NEUROTROPHIC FACTOR; OXIDATIVE STRESS; BIPOLAR DISORDER; DOUBLE-BLIND; MAJOR DEPRESSION; AMYLOID-BETA; IN-VITRO; BRAIN; SCHIZOPHRENIA;
D O I
10.1002/ptr.8265
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Psychiatric disorders cause long-lasting disabilities across different age groups. While various medications are available for mental disorders, some patients do not fully benefit from them or experience treatment resistance. The pathogenesis of psychiatric disorders involves multiple mechanisms, including an increase in the inflammatory response. Targeting inflammatory mechanisms has shown promise as a therapeutic approach for these disorders. Curcumin, known for its anti-inflammatory properties and potential neuroprotective effects, has been the subject of studies investigating its potential as a treatment option for psychiatric disorders. This review comprehensively examines the potential therapeutic role of curcumin and its nanoformulations in psychiatric conditions, including major depressive disorder (MDD), bipolar disorder, schizophrenia, and anxiety disorders. There is lack of robust clinical trials across all the studied psychiatric disorders, particularly bipolar disorder and schizophrenia. More studies have focused on MDD. Studies on depression indicate that curcumin may be effective as an antidepressant agent, either alone or as an adjunct therapy. However, inconsistencies exist among study findings, highlighting the need for further research with improved blinding, optimized dosages, and treatment durations. Limited evidence supports the use of curcumin for bipolar disorder, making its therapeutic application challenging. Well-designed clinical trials are warranted to explore its potential therapeutic benefits. Exploring various formulations and delivery strategies, such as utilizing liposomes and nanoparticles, presents intriguing avenues for future research. More extensive clinical trials are needed to assess the efficacy of curcumin as a standalone or adjunctive treatment for psychiatric disorders, focusing on optimal dosages, formulations, and treatment durations. Curcumin and nano-curcumin applications for psychiatric disorders. image
引用
收藏
页码:4240 / 4260
页数:21
相关论文
共 50 条
  • [1] Effect of curcumin, and nano-curcumin on sperm function in varicocele rat model
    Sadraei, Mohamad Reza
    Tavalaee, Marziyeh
    Forouzanfar, Mohsen
    Nasr-Esfahani, Mohammad Hossein
    ANDROLOGIA, 2022, 54 (01)
  • [2] Biocompatibility of A Nano-curcumin Pulpal Paste in Rats
    Sahebalam, Rasoul
    Shirazi, Alireza Sarraf
    Ghazi, Narges
    Gifani, Mahshid
    Sabzevari, Berahman
    GALEN MEDICAL JOURNAL, 2024, 13
  • [3] Nano-curcumin versus curcumin in amelioration of deltamethrin-induced hippocampal damage
    Zaki, Sherif Mohamed
    Abd Algaleel, Waleed Ahmed
    Imam, Reda Abdelnasser
    Soliman, Ghada F.
    Ghoneim, Fatma M.
    HISTOCHEMISTRY AND CELL BIOLOGY, 2020, 154 (02) : 157 - 175
  • [4] Nano-curcumin versus curcumin in amelioration of deltamethrin-induced hippocampal damage
    Sherif Mohamed Zaki
    Waleed Ahmed Abd Algaleel
    Reda Abdelnasser Imam
    Ghada F. Soliman
    Fatma M. Ghoneim
    Histochemistry and Cell Biology, 2020, 154 : 157 - 175
  • [5] Modulation of the Proteasome Pathway by Nano-Curcumin and Curcumin in Retinal Pigment Epithelial Cells
    de Carvalho, J. Emanuel Ramos
    Verwoert, Milan T.
    Vogels, Ilse M. C.
    Schipper-Krom, Sabine
    Van Noorden, Cornelis J. F.
    Reits, Eric A.
    Klaassen, Ingeborg
    Schlingemann, Reinier O.
    OPHTHALMIC RESEARCH, 2018, 59 (02) : 98 - 109
  • [6] Bioavailability of curcumin and curcumin glucuronide in the central nervous system of mice after oral delivery of nano-curcumin
    Szymusiak, Magdalena
    Hu, Xiaoyu
    Plata, Paola A. Leon
    Ciupinski, Paulina
    Wang, Zaijie Jim
    Liu, Ying
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2016, 511 (01) : 415 - 423
  • [7] Photoinactivation Effects of Curcumin, Nano-curcumin, and Erythrosine on Planktonic and Biofilm Cultures of Streptococcus mutans
    Ahrari, Farzaneh
    Nazifi, Morteza
    Mazhari, Fatemeh
    Ghazvini, Kiarash
    Menbari, Shaho
    Fekrazad, Reza
    Babaei, Kourosh
    Banihashemrad, Ahmad
    JOURNAL OF LASERS IN MEDICAL SCIENCES, 2024, 15
  • [8] Nano-curcumin formulations for targeted therapy of colorectal cancer
    Sardou, Hossein Shahdadi
    Nazari, Seyedeh Elnaz
    Abbaspour, Mohammadreza
    Akhgari, Abbas
    Sheikh, Afsana
    Kesharwani, Prashant
    Sahebkar, Amirhossein
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2023, 88
  • [9] Protective action of curcumin and nano-curcumin against arsenic-induced genotoxicity in rats in vivo
    Palanisamy Sankar
    Avinash Gopal Telang
    Kalaivanan Ramya
    Karunakaran Vijayakaran
    Manickam Kesavan
    Souvendra Nath Sarkar
    Molecular Biology Reports, 2014, 41 : 7413 - 7422
  • [10] Protective action of curcumin and nano-curcumin against arsenic-induced genotoxicity in rats in vivo
    Sankar, Palanisamy
    Telang, Avinash Gopal
    Ramya, Kalaivanan
    Vijayakaran, Karunakaran
    Kesavan, Manickam
    Sarkar, Souvendra Nath
    MOLECULAR BIOLOGY REPORTS, 2014, 41 (11) : 7413 - 7422